IT1285405B1 - Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. - Google Patents

Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.

Info

Publication number
IT1285405B1
IT1285405B1 IT96TO000496A ITTO960496A IT1285405B1 IT 1285405 B1 IT1285405 B1 IT 1285405B1 IT 96TO000496 A IT96TO000496 A IT 96TO000496A IT TO960496 A ITTO960496 A IT TO960496A IT 1285405 B1 IT1285405 B1 IT 1285405B1
Authority
IT
Italy
Prior art keywords
electrotransport
modification
increase flow
polypeptide drugs
polypeptide
Prior art date
Application number
IT96TO000496A
Other languages
English (en)
Inventor
Leslie A Holladay
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ITTO960496A0 publication Critical patent/ITTO960496A0/it
Publication of ITTO960496A1 publication Critical patent/ITTO960496A1/it
Application granted granted Critical
Publication of IT1285405B1 publication Critical patent/IT1285405B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Electrotherapy Devices (AREA)
IT96TO000496A 1995-06-06 1996-06-05 Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. IT1285405B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46661095A 1995-06-06 1995-06-06

Publications (3)

Publication Number Publication Date
ITTO960496A0 ITTO960496A0 (it) 1996-06-05
ITTO960496A1 ITTO960496A1 (it) 1997-12-05
IT1285405B1 true IT1285405B1 (it) 1998-06-03

Family

ID=23852435

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96TO000496A IT1285405B1 (it) 1995-06-06 1996-06-05 Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.

Country Status (12)

Country Link
US (2) US7324846B2 (it)
JP (2) JP4354529B2 (it)
AU (1) AU6590396A (it)
BE (1) BE1009704A3 (it)
BR (1) BR9609149A (it)
CA (1) CA2220146A1 (it)
DE (1) DE19681439T1 (it)
FR (1) FR2735132B1 (it)
GB (1) GB2317179B (it)
IT (1) IT1285405B1 (it)
NL (1) NL1003283C2 (it)
WO (1) WO1996039422A2 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1285405B1 (it) * 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
DE60031709T2 (de) 1999-10-14 2007-06-28 Pola Chemical Industries, Inc. Zusammensetzungen für die elektroporation
AU9084601A (en) * 2000-09-08 2002-03-22 Massachusetts Inst Technology G-csf analog compositions and methods
WO2004022033A1 (en) * 2002-09-04 2004-03-18 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
EP1539959A2 (en) * 2002-09-18 2005-06-15 Centre Hospitalier de l'Université de Montréal (CHUM) Ghrh analogues
AU2006208131A1 (en) 2005-01-25 2006-08-03 Microchips, Inc. Control of drug release by transient modification of local microenvironments
MX2012010148A (es) 2010-03-04 2013-01-22 Pfenex Inc Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion.
PL2552949T3 (pl) 2010-04-01 2017-01-31 Pfenex Inc. Sposoby wytwarzania G-CSF w komórce gospodarza Pseudomonas
AU2012345777B2 (en) 2011-11-30 2016-05-12 Kindeva Drug Delivery L.P. Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
ES2939940T3 (es) 2014-03-28 2023-04-28 Univ Duke Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
MX384605B (es) 2015-04-29 2025-03-14 Radius Pharmaceuticals Inc Combinación de palbociclib y rad1901 para usarse en el tratamiento de cáncer de mama en un sujeto con cáncer positivo a receptor de estrógeno.
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl
US12441745B2 (en) 2019-02-12 2025-10-14 Radius Pharmaceuticals, Inc. Processes and compounds

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250878A (en) 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4628043A (en) * 1983-04-26 1986-12-09 The Salk Institute For Biological Studies Hypothalamic GRF agonists
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4722726A (en) 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US5250022A (en) 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
AU609769B2 (en) 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
DK10191D0 (da) 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
CA2087087C (en) 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules for iontophoretic delivery
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
AU4534593A (en) * 1992-06-12 1994-01-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
ATE190233T1 (de) * 1992-12-31 2000-03-15 Alza Corp Elektrotransporteinrichtung
WO1994028967A1 (en) * 1993-06-08 1994-12-22 Hisamitsu Pharmaceutical Co., Inc. Iontophoresis system
ATE211655T1 (de) * 1993-09-22 2002-01-15 Hisamitsu Pharmaceutical Co Iontophoresematrix
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
IT1285405B1 (it) * 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.

Also Published As

Publication number Publication date
AU6590396A (en) 1996-12-24
ITTO960496A1 (it) 1997-12-05
NL1003283C2 (nl) 1997-05-02
IE960413A1 (en) 1996-12-11
DE19681439T1 (de) 1998-07-23
JP2009149639A (ja) 2009-07-09
NL1003283A1 (nl) 1996-12-09
FR2735132A1 (fr) 1996-12-13
BE1009704A3 (fr) 1997-07-01
JP4354529B2 (ja) 2009-10-28
ITTO960496A0 (it) 1996-06-05
JPH11507341A (ja) 1999-06-29
US7324846B2 (en) 2008-01-29
CA2220146A1 (en) 1996-12-12
US20020107505A1 (en) 2002-08-08
WO1996039422A3 (en) 1997-03-06
GB2317179A (en) 1998-03-18
GB2317179B (en) 1999-07-28
GB9725981D0 (en) 1998-02-04
BR9609149A (pt) 1999-02-23
US20090275877A1 (en) 2009-11-05
FR2735132B1 (fr) 1998-04-24
WO1996039422A2 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ATE196463T1 (de) Assymetrische synthese von (-) 6-chloro-4-
FI863153A7 (fi) Mellanprodukter i polypeptidsyntesen.
FI862908L (fi) Shampookompositioner.
ATE183650T1 (de) Interferon-lösung
DE3672165D1 (de) Kapazitive bruecke.
DE3678356D1 (de) Fluessige shampoozusammensetzung.
DE3672924D1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
DE69531218D1 (de) Verbesserung des ertrages von pflanzen
DE59303259D1 (de) Membranpumpe
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
DE69518743D1 (de) Modifizierung von nukleotidanalogen
DE3683626D1 (de) Elektrostatischer luft-ultraschallwandler.
IT8522977A0 (it) Purificiazione di l-fenilalanina.
DE69609600D1 (de) Verbesserte chemilumineszente lösung
DK247890D0 (da) Gensyntese
DE69316307D1 (de) Vibrator
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
EP0229107A4 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
NO951679D0 (no) Fibronektin-bindende protein, samt fremstilling derav
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
NO890692L (no) Element for takstige.
KR970048514U (ko) 폰잭 캔의 구조
ITTV950114A0 (it) Struttura di tavolino-sgabello
MX9203467A (es) Derivados de peptidos.

Legal Events

Date Code Title Description
0001 Granted